Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000899140-26-000333·IRONWOOD PHARMACEUTICALS INC
Schedule 13D ownership disclosure
Ironwood Pharmaceuticals Inc
Class A Common Stock, $0.001 par value · CUSIP: 46333X108
Event date: 2026-03-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Sarissa Capital Management LPReported CIK 0001577524
Shares: 9,188,635 · Class: 5.6%
- Alexander J. Denner
Shares: 9,444,944 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-26-000333
- Form type
- SCHEDULE 13D/A
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- Mar 19, 2026
- Reporting period
- Mar 17, 2026
- Description
- Schedule 13D beneficial ownership